MYRON NEVINS
Dentist in Swampscott, MA
License number
Pennsylvania DS016030L
Category
Dentistry
Type
Dentist
Address
Address
2
Swampscott, MA 01907
Pennsylvania
Pennsylvania
Organization information
See more information about MYRON NEVINS at bizstanding.comMyron Nevins DDS
90 Humphrey St, Swampscott, MA 01907
Industry:
Dentists, Oral Surgeons
Phone:
(781) 596-2220 (Phone)
Description:
There are 6 doctors at this site. Surgery is not performed at this site.
Myron Nevins
Professional information
Dr. Myron Nevins, Swampscott MA - DDS (Doctor of Dental Surgery)
Specialties:
Periodontics
Address:
90 Humphrey St, Swampscott 01907
(781) 596-2220 (Phone), (781) 598-8050 (Fax)
(781) 596-2220 (Phone), (781) 598-8050 (Fax)
Languages:
English
Education:
Medical School
Graduates of Institutions Not Listed As Medical Schools
Graduates of Institutions Not Listed As Medical Schools
Myron L Nevins, Swampscott MA
Specialties:
Dentist
Address:
90 Humphrey St, Swampscott, MA 01907
Maxillofacial Bone Augmentation Using Rhpdgf-Bb And A Biocompatible Matrix
US Patent:
2012012, May 24, 2012
Filed:
Jan 5, 2012
Appl. No.:
13/344506
Inventors:
Samuel E. Lynch - Franklin TN, US
Myron Nevins - Swampscott MA, US
Massimo Simion - Milano, IT
Myron Nevins - Swampscott MA, US
Massimo Simion - Milano, IT
Assignee:
BIOMIMETIC THERAPEUTICS, INC. - Franklin TN
International Classification:
A61K 9/14, A61P 43/00, A61P 19/10, A61K 38/18, A61P 19/08
US Classification:
424484, 514 82
Abstract:
The present invention provides effective new methods and materials for maxillofacial bone augmentation, particularly alveolar ridge augmentation, that are free of problems associated with prior art methods. In one embodiment, these materials include human recombinant platelet derived growth factor (rhPDGF-BB) and a biocompatible matrix. In another embodiment, these materials include rhPDGF-BB, a deproteinized bone block or calcium phosphate, and a bioresorbable membrane. The use of these materials in the present method is effective in regenerating maxillofacial bones and facilitating achievement of stable osseointegrated implants. The mandible and maxilla are preferred bones for augmentation, and enhancement of the alveolar ridge is a preferred embodiment of the present invention.
Maxillofacial Bone Augmentation Using Rhpdgf-Bb And A Biocompatible Matrix
US Patent:
2007012, Jun 7, 2007
Filed:
Nov 17, 2006
Appl. No.:
11/601376
Inventors:
Samuel Lynch - Franklin TN, US
Myron Nevins - Swampscott MA, US
Massimo Simion - Milano, IT
Myron Nevins - Swampscott MA, US
Massimo Simion - Milano, IT
International Classification:
A61F 2/02, A61F 2/28, C12N 5/08
US Classification:
623017170, 623017180, 435384000
Abstract:
The present invention provides effective new methods and materials for maxillofacial bone augmentation, particularly alveolar ridge augmentation, that are free of problems associated with prior art methods. In one embodiment, these materials include human recombinant platelet derived growth factor (rhPDGF-BB) and a biocompatible matrix. In another embodiment, these materials include rhPDGF-BB, a deproteinized bone block or calcium phosphate, and a bioresorbable membrane. The use of these materials in the present method is effective in regenerating maxillofacial bones and facilitating achievement of stable osseointegrated implants. The mandible and maxilla are preferred bones for augmentation, and enhancement of the alveolar ridge is a preferred embodiment of the present invention.
Methods And Compositions For Detecting And Modulating Periodontal Disorders And Periodontal Diseases
US Patent:
2008002, Jan 31, 2008
Filed:
Jul 6, 2007
Appl. No.:
11/774095
Inventors:
Joseph Fiorellini - Merion Station PA, US
Myron Nevins - Swampscott MA, US
David Kim - Cambridge MA, US
Marco Ramoni - Boston MA, US
Myron Nevins - Swampscott MA, US
David Kim - Cambridge MA, US
Marco Ramoni - Boston MA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12Q 1/37, A61K 45/00, A61P 43/00, G01N 33/50, C12Q 1/02
US Classification:
514789000, 435023000, 435029000, 436086000, 436087000
Abstract:
The invention provides genetic markers of periodontal disorders and/or periodontal diseases. The present invention provides methods and compositions to aid in the detection, diagnosis, treatment and monitoring of periodontal disorders and/or periodontal diseases.